Twofer anti-vascular therapy targeting sphingosine-1-phosphate for breast cancer.

Autor: Takabe K; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States., Yamada A; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States., Rashid OM; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States., Adams BJ; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States., Huang WC; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States., Aoyagi T; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States., Nagahashi M; Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University School of Medicine and Massey Cancer Center, Richmond, VA 23298-0011, United States.
Jazyk: angličtina
Zdroj: Gland surgery [Gland Surg] 2012 Aug 01; Vol. 1 (2), pp. 80-83.
DOI: 10.3978/j.issn.2227-684X.2012.07.01
Databáze: MEDLINE